From lung hypersensitivity to bronchial hyperreactivity. What can we learn from studies on animal models?
Pretolani
M
M
Unité de Pharmacologie cellulaire, Institut Pasteur, Paris, France.
Vargaftig
B B
BB
D000818:Animals; D001249:Asthma / Q000503:physiopathology*; D016535:Bronchial Hyperreactivity / Q000503:physiopathology*; D016207:Cytokines / Q000502:physiology; D004195:Disease Models, Animal; D004804:Eosinophils / Q000502:physiology; D006168:Guinea Pigs; D006801:Humans; D008214:Lymphocytes / Q000502:physiology; D010972:Platelet Activating Factor / Q000502:physiology; D012130:Respiratory Hypersensitivity / Q000503:physiopathology*
D016207:Cytokines; D010972:Platelet Activating Factor